Drug profile · INN
doxycycline calcium
VIBRAMYCIN
doxycycline calcium (VIBRAMYCIN) is a matrix metalloproteinase 8 inhibitor. Route of administration: oral. Current US regulatory status: approved.
Drug details — doxycycline calcium
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
doxycycline calcium (VIBRAMYCIN) is a matrix metalloproteinase 8 inhibitor. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Matrix metalloproteinase 8 inhibitor
Primary target: Collagenase 3
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Frequently asked questions
What is doxycycline calcium?
doxycycline calcium (VIBRAMYCIN) is a matrix metalloproteinase 8 inhibitor. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for doxycycline calcium?
VIBRAMYCIN is a marketed brand name for doxycycline calcium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of doxycycline calcium?
doxycycline calcium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.